Matinas BioPharma Holdings MTNB
NYSE MTNB
$2.61 +0.17 (+6.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Matinas BioPharma Holdings (MTNB) Return on Sales [ROS] (2015 - 2023)

Updated

Matinas BioPharma Holdings (MTNB) recorded Return on Sales [ROS] of -2168.43% in Q4 2023, down 1652.91 percentage points from -515.52% a year earlier and down 1086.49 percentage points from the prior quarter.

Analysis

Matinas BioPharma Holdings (MTNB) Return on Sales [ROS] (2015 - 2023) Analysis & Trends

Starting with Q1 2015, Matinas BioPharma Holdings' Return on Sales [ROS] history includes 30 quarters.

  • Annual Return on Sales [ROS] has a five-year change of +10062.50 percentage points (FY2018 to FY2023).
  • Across earlier years, Return on Sales [ROS] came in at -771.33% in FY2022 (+74183.22 pp), -74954.55% in FY2021 (-59666.16 pp), -15288.38% in FY2020 (+5779.00 pp) and -21067.38% in FY2019 (-8836.45 pp).
  • The Q4 2023 figure is the lowest quarterly Return on Sales [ROS] since Q4 2021.
  • On a year-over-year basis, Return on Sales [ROS] has declined for three consecutive quarters, with an average year-over-year change of +18116.45 percentage points over the last six quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 74439.02 percentage points in Q4 2022, against a drop of 64572.33 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -1081.94% (Q3 2023), -704.13% (Q2 2023) and -509.67% (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 28.21%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 37.86%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 32.97%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 20.57%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -133.21%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 28.37%
10 Matinas BioPharma Holdings 15.63 Mn 3.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -2,168.43%
Sep 30, 2023 -1,081.94%
Jun 30, 2023 -704.13%
Mar 31, 2023 -509.67%
Dec 31, 2022 -515.52%
Sep 30, 2022 -513.83%
Jun 30, 2022 -557.38%
Dec 31, 2021 -74,954.55%
Sep 30, 2021 -25,575.35%
Jun 30, 2021 -12,123.32%
Mar 31, 2021 -19,059.52%
Dec 31, 2020 -10,382.22%
Sep 30, 2020 -5,848.30%
Dec 31, 2019 -21,067.38%
Sep 30, 2019 -19,320.00%
Jun 30, 2019 -5,033.49%
Dec 31, 2018 -12,230.93%
Sep 30, 2018 -9,177.01%
Jun 30, 2018 -3,791.13%
Mar 31, 2018 -13,764.74%
API Access

Matinas BioPharma Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MTNB&period=max&api_key=YOUR_API_KEY